H-020

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameH-020
Drug Alias NameH-020
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitorsAsialoglycoprotein receptor 1 inhibitors
TargetsAsialoglycoprotein receptor 1Proprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Genepharma Co LtdJiangsu Carephar Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Genepharma Co LtdJiangsu Carephar Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A